Cargando…

High prevalence of liver fibrosis among general population: a Romanian population-based study

Although high mortality is associated with liver cirrhosis, patients usually have a good quality of life in the compensated phase, and the disease may progress undiagnosed for many years. Vibration-controlled transient elastography with controlled attenuation parameter is a useful noninvasive tool u...

Descripción completa

Detalles Bibliográficos
Autores principales: Trifan, Anca, Muzica, Cristina-Maria, Nastasa, Robert, Zenovia, Sebastian, Stratina, Ermina, Stafie, Remus, Rotaru, Adrian, Singeap, Ana-Maria, Cojocariu, Camelia, Sfarti, Catalin, Girleanu, Irina, Chiriac, Stefan, Cuciureanu, Tudor, Huiban, Laura, Stanciu, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851682/
https://www.ncbi.nlm.nih.gov/pubmed/36691959
http://dx.doi.org/10.1097/HC9.0000000000000032
_version_ 1784872457511895040
author Trifan, Anca
Muzica, Cristina-Maria
Nastasa, Robert
Zenovia, Sebastian
Stratina, Ermina
Stafie, Remus
Rotaru, Adrian
Singeap, Ana-Maria
Cojocariu, Camelia
Sfarti, Catalin
Girleanu, Irina
Chiriac, Stefan
Cuciureanu, Tudor
Huiban, Laura
Stanciu, Carol
author_facet Trifan, Anca
Muzica, Cristina-Maria
Nastasa, Robert
Zenovia, Sebastian
Stratina, Ermina
Stafie, Remus
Rotaru, Adrian
Singeap, Ana-Maria
Cojocariu, Camelia
Sfarti, Catalin
Girleanu, Irina
Chiriac, Stefan
Cuciureanu, Tudor
Huiban, Laura
Stanciu, Carol
author_sort Trifan, Anca
collection PubMed
description Although high mortality is associated with liver cirrhosis, patients usually have a good quality of life in the compensated phase, and the disease may progress undiagnosed for many years. Vibration-controlled transient elastography with controlled attenuation parameter is a useful noninvasive tool used to estimate both the severity of fibrosis and steatosis. Hence, we aimed to establish the prevalence of significant liver fibrosis diagnosed by vibration-controlled transient elastography in an apparently healthy population. Between December 2021 and March 2022, we conducted a prospective screening of liver fibrosis in apparently healthy participants from different counties of Northeastern Romania. All subjects’ medical history was recorded through a comprehensive questionnaire and underwent a liver stiffness measurement. Participants with abnormal liver stiffness measurement values were further evaluated by laboratory tests to identify the etiology of chronic liver disease. A total of 127 apparently healthy subjects were enrolled, mainly females (59.8%), with a mean age of 56±11 years. Overall, 12.6% of participants were found to have significant to advanced fibrosis, and 5.4% had liver cirrhosis. Among 184 participants with clinically significant fibrosis (≥8.0 kPa), 26.1% had a history of heavy alcohol intake, 22.3% tested positive for hepatitis B and C infection, and 2.1% with other etiologies. The remaining 49.5% participants with clinically significant fibrosis were diagnosed with NAFLD, with a mean controlled attenuation parameter value of 282±34 dB/m. The high prevalence of significant liver fibrosis in the general population of Romania is alarming and should raise awareness among clinicians and public health systems. Vibration-controlled transient elastography has demonstrated its usefulness as a screening tool to identify advanced liver fibrosis in general population and should be used in liver disease prevention strategies.
format Online
Article
Text
id pubmed-9851682
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-98516822023-03-16 High prevalence of liver fibrosis among general population: a Romanian population-based study Trifan, Anca Muzica, Cristina-Maria Nastasa, Robert Zenovia, Sebastian Stratina, Ermina Stafie, Remus Rotaru, Adrian Singeap, Ana-Maria Cojocariu, Camelia Sfarti, Catalin Girleanu, Irina Chiriac, Stefan Cuciureanu, Tudor Huiban, Laura Stanciu, Carol Hepatol Commun Original Articles Although high mortality is associated with liver cirrhosis, patients usually have a good quality of life in the compensated phase, and the disease may progress undiagnosed for many years. Vibration-controlled transient elastography with controlled attenuation parameter is a useful noninvasive tool used to estimate both the severity of fibrosis and steatosis. Hence, we aimed to establish the prevalence of significant liver fibrosis diagnosed by vibration-controlled transient elastography in an apparently healthy population. Between December 2021 and March 2022, we conducted a prospective screening of liver fibrosis in apparently healthy participants from different counties of Northeastern Romania. All subjects’ medical history was recorded through a comprehensive questionnaire and underwent a liver stiffness measurement. Participants with abnormal liver stiffness measurement values were further evaluated by laboratory tests to identify the etiology of chronic liver disease. A total of 127 apparently healthy subjects were enrolled, mainly females (59.8%), with a mean age of 56±11 years. Overall, 12.6% of participants were found to have significant to advanced fibrosis, and 5.4% had liver cirrhosis. Among 184 participants with clinically significant fibrosis (≥8.0 kPa), 26.1% had a history of heavy alcohol intake, 22.3% tested positive for hepatitis B and C infection, and 2.1% with other etiologies. The remaining 49.5% participants with clinically significant fibrosis were diagnosed with NAFLD, with a mean controlled attenuation parameter value of 282±34 dB/m. The high prevalence of significant liver fibrosis in the general population of Romania is alarming and should raise awareness among clinicians and public health systems. Vibration-controlled transient elastography has demonstrated its usefulness as a screening tool to identify advanced liver fibrosis in general population and should be used in liver disease prevention strategies. Lippincott Williams & Wilkins 2023-01-18 /pmc/articles/PMC9851682/ /pubmed/36691959 http://dx.doi.org/10.1097/HC9.0000000000000032 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Articles
Trifan, Anca
Muzica, Cristina-Maria
Nastasa, Robert
Zenovia, Sebastian
Stratina, Ermina
Stafie, Remus
Rotaru, Adrian
Singeap, Ana-Maria
Cojocariu, Camelia
Sfarti, Catalin
Girleanu, Irina
Chiriac, Stefan
Cuciureanu, Tudor
Huiban, Laura
Stanciu, Carol
High prevalence of liver fibrosis among general population: a Romanian population-based study
title High prevalence of liver fibrosis among general population: a Romanian population-based study
title_full High prevalence of liver fibrosis among general population: a Romanian population-based study
title_fullStr High prevalence of liver fibrosis among general population: a Romanian population-based study
title_full_unstemmed High prevalence of liver fibrosis among general population: a Romanian population-based study
title_short High prevalence of liver fibrosis among general population: a Romanian population-based study
title_sort high prevalence of liver fibrosis among general population: a romanian population-based study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851682/
https://www.ncbi.nlm.nih.gov/pubmed/36691959
http://dx.doi.org/10.1097/HC9.0000000000000032
work_keys_str_mv AT trifananca highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT muzicacristinamaria highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT nastasarobert highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT zenoviasebastian highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT stratinaermina highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT stafieremus highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT rotaruadrian highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT singeapanamaria highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT cojocariucamelia highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT sfarticatalin highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT girleanuirina highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT chiriacstefan highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT cuciureanutudor highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT huibanlaura highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy
AT stanciucarol highprevalenceofliverfibrosisamonggeneralpopulationaromanianpopulationbasedstudy